Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Citius Pharmaceuticals, Inc. | Chief Executive Officer, Director, 10%+ Owner | Common Stock | 10.3M | $7.69M | $0.75 | Apr 3, 2024 | Direct |
CITIUS ONCOLOGY, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 3.7M | Aug 12, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Chief Executive Officer, Director, 10%+ Owner | Warrant to Purchase Common Stock | 1.17M | Apr 3, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Chief Executive Officer, Director, 10%+ Owner | Option to Purchase Common Stock | 550K | Oct 10, 2023 | Direct | ||
Citius Pharmaceuticals, Inc. | Chief Executive Officer, Director, 10%+ Owner | Stock Option (Right to Purchase Common Stock) | 40K | Apr 3, 2024 | Direct | ||
Tharimmune, Inc. | Director | Options (right to buy) | 27.4K | Aug 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 1 | $0 | 4/A | Aug 30, 2024 | Chief Executive Officer, Director |
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Chief Executive Officer, Director |
THAR | Tharimmune, Inc. | Aug 9, 2024 | 1 | $0 | 4 | Aug 12, 2024 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Apr 3, 2024 | 2 | $0 | 4 | Apr 5, 2024 | Chief Executive Officer, Director, 10%+ Owner |
CTXR | Citius Pharmaceuticals, Inc. | Oct 10, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Chief Executive Officer, Director, 10%+ Owner |
THAR | Tharimmune, Inc. | Nov 7, 2022 | 1 | $0 | 4 | Nov 9, 2023 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Oct 4, 2022 | 0 | $0 | 4/A | Nov 15, 2022 | Executive Chairman, Director, 10%+ Owner |
HILS | Hillstream BioPharma Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | Director |
HILS | Hillstream BioPharma Inc. | Jan 14, 2022 | 3 | $116K | 4 | Jan 18, 2022 | Director |
HILS | Hillstream BioPharma Inc. | Jan 11, 2022 | 0 | $0 | 3 | Jan 11, 2022 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Oct 11, 2021 | 1 | $0 | 4 | Oct 13, 2021 | Executive Chairman, Director, 10%+ Owner |
CTXR | Citius Pharmaceuticals, Inc. | Jul 22, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Executive Chairman, Director, 10%+ Owner |